Zhishan Wu

机构：University of New Orleans, University Medical Center New Orleans, Hunan Provincial Center for Disease Control and Prevention, Volunteer Research Group and New Orleans Center for Clinical Research, First Hospital of Lanzhou University, Lanzhou University · ORCID：0009-0006-1005-6958

发表论文 41 篇 · 总被引 376 次 · h-index 11

代表论文

• Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma (2023 · Scientific Reports · 被引 30)
• Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease (2023 · Journal of Ethnopharmacology · 被引 29)
• Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway (2023 · Phytomedicine · 被引 24)
• The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR (2023 · Journal of Ethnopharmacology · 被引 17)
• Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments (2023 · Chinese Medicine · 被引 13)
• A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid (2025 · Pharmacoepidemiology and Drug Safety · 被引 10)